Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.
Saved in:
| Title: | Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma. |
|---|---|
| Authors: | Barrios, Carlos H.1, Hernandez-Barajas, David2, Brown, Michael P.3, Lee, Se-Hoon4, Fein, Luis5, Liu, Jin-Hwang6, Hariharan, Subramanian7, Martell, Bridget A.7, Yuan, Jinyu7, Bello, Akintunde7, Wang, Zhixiao8, Mundayat, Rajiv7, Rha, Sun-Young9 |
| Source: | Cancer (0008543X). Mar2012, Vol. 118 Issue 5, p1252-1259. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
